Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Moodys
Cerilliant
Daiichi Sankyo
Queensland Health
McKinsey
Fuji
Colorcon
Farmers Insurance
Johnson and Johnson

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050802

« Back to Dashboard

NDA 050802 describes ZIANA, which is a drug marketed by Medicis and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the ZIANA profile page.

The generic ingredient in ZIANA is clindamycin phosphate; tretinoin. There are fifty-four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.
Summary for 050802
Tradename:ZIANA
Applicant:Medicis
Ingredient:clindamycin phosphate; tretinoin
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 050802
Suppliers and Packaging for NDA: 050802
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZIANA clindamycin phosphate; tretinoin GEL;TOPICAL 050802 NDA Medicis Pharmaceutical Corp 99207-300 N 99207-300-60
ZIANA clindamycin phosphate; tretinoin GEL;TOPICAL 050802 NDA Medicis Pharmaceutical Corp 99207-300 N 99207-300-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength1.2%;0.025%
Approval Date:Nov 7, 2006TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Aug 3, 2020Product Flag?YSubstance Flag?Delist Request?
Patented Use:TOPICAL TREATMENT OF ACNE VULGARIS IN PATIENTS 12 YEARS OR OLDER

Expired US Patents for NDA 050802

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medicis ZIANA clindamycin phosphate; tretinoin GEL;TOPICAL 050802-001 Nov 7, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Medicis ZIANA clindamycin phosphate; tretinoin GEL;TOPICAL 050802-001 Nov 7, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cerilliant
Argus Health
Baxter
Cipla
Citi
Boehringer Ingelheim
Moodys
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot